What is Belsomra?
Belsomra is a prescription medication used to treat insomnia, a sleep disorder that makes it difficult for individuals to fall or stay asleep. It belongs to a class of drugs known as orexin receptor antagonists, which work by blocking the effects of a brain neurotransmitter called orexin, which helps regulate the wake-sleep cycle.
Unlike other sleep drugs, Belsomra does not function as a sedative. Instead, it helps to quiet the parts of the brain that are active during wakefulness, making it easier for individuals to fall asleep and stay asleep throughout the night. It comes in the form of small tablets that are taken orally, usually 30 minutes before bedtime and with or without food.
The effectiveness of Belsomra may vary from person to person, and doctors typically start patients on a lower dose before gradually increasing it if needed. It is important to take Belsomra exactly as prescribed to avoid any unwanted side effects.
Common side effects of Belsomra include headaches, drowsiness, dry mouth, and feelings of dizziness or lightheadedness. In rare cases, Belsomra may cause more serious side effects, such as sleepwalking and other abnormal behaviors during sleep.
Overall, Belsomra can be an effective treatment option for individuals struggling with insomnia. However, it is important to consult with a healthcare provider before starting any new medication to determine if it is the right choice for your individual needs and medical history.
Frequently Asked Questions about belsomra
Merck's Insomnia Medicine BELSOMRA® (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States - Merck.com.
This medication is used to treat a certain sleep problem (insomnia). It may help you fall asleep and stay asleep longer, so you can get a better night's rest. Suvorexant belongs to a class of drugs known as sedative-hypnotics.
Belsomra is a prescription brand-name medication. It's FDA-approved to treat insomnia (trouble sleeping) in adults.
Belsomra has an average rating of 3.6 out of 10 from a total of 484 reviews for the treatment of Insomnia. 25% of reviewers reported a positive experience, while 65% reported a negative experience.
Belsomra was first FDA-approved for the treatment of insomnia in 2014.
BELSOMRA is a controlled substance because it can be abused or cause dependence. Before taking BELSOMRA, tell your doctor about all of your medical conditions, including if you: have a history of depression, mental illness, or suicidal thoughts.
Belsomra is only available as a brand-name drug. It doesn't come in a generic version. A generic drug is an exact copy of the active drug in a brand-name medication. Generics tend to cost less than brand-name drugs.
BELSOMRA is a prescription medicine for adults who have trouble falling or staying asleep (insomnia). It is not known if BELSOMRA is safe and effective in children under the age of 18 years.
In clinical studies, Belsomra was given for up to 3 months to patients with insomnia (trouble sleeping), but only take Belsomra as long as your doctor recommends. Call your doctor if your insomnia worsens or is not better within 7 to 10 days.
increased sinus/throat infections. memory problems. signs of depression or worsening depression (e.g., poor concentration, changes in weight, changes in sleep, decreased interest in activities, thoughts of suicide) sleep-paralysis (inability to move or speak when going to sleep or waking up)
Abuse of BELSOMRA poses an increased risk of somnolence, daytime sleepiness, impaired reaction time, and impaired driving skills. Patients at risk for abuse may include those with prolonged use of BELSOMRA, those with a history of drug abuse, and those who use BELSOMRA in combination with alcohol or other abused drugs.
The cost for Belsomra oral tablet 5 mg is around $455 for a supply of 30 tablets, depending on the pharmacy you visit.
BELSOMRA is a controlled substance because it can be abused or cause dependence. Before taking BELSOMRA, tell your doctor about all of your medical conditions, including if you: have a history of depression, mental illness, or suicidal thoughts.
In clinical studies, Belsomra was given for up to 3 months to patients with insomnia (trouble sleeping), but only take Belsomra as long as your doctor recommends. Call your doctor if your insomnia worsens or is not better within 7 to 10 days.
increased sinus/throat infections. memory problems. signs of depression or worsening depression (e.g., poor concentration, changes in weight, changes in sleep, decreased interest in activities, thoughts of suicide) sleep-paralysis (inability to move or speak when going to sleep or waking up)
